Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG20041)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-494-3p
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Responsed Disease | Myeloid leukaemia | ICD-11: 2B33 | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Gluconeogenesis | hsa00010 | |||
| Apoptosis | hsa04210 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
| Cell apoptosis | ||||
In Vitro Model |
Kasumi-1 cells | Acute myeloid leukemia | Homo sapiens | CVCL_0589 |
| KG-1 cells | Adult acute myeloid leukemia | Homo sapiens | CVCL_0374 | |
| Response regulation | Circ_0000745 promoted cell cycle progression and glycolytic metabolism and inhibited the apoptosis and ferroptosis of acute lymphoblastic leukemia cells by regulating miR-494-3p/NET1 axis. Circ_0000745/ miR-494-3p/NET1 axis may provide novel potential targets for the diagnosis and treatment of acute lymphoblastic leukemia (ALL). | |||
Myeloid leukaemia [ICD-11: 2B33]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | hsa-miR-494-3p (miRNA) | miRNA | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Gluconeogenesis | hsa00010 | |||
| Apoptosis | hsa04210 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
| Cell apoptosis | ||||
In Vitro Model |
Kasumi-1 cells | Acute myeloid leukemia | Homo sapiens | CVCL_0589 |
| KG-1 cells | Adult acute myeloid leukemia | Homo sapiens | CVCL_0374 | |
| Response regulation | Circ_0000745 promoted cell cycle progression and glycolytic metabolism and inhibited the apoptosis and ferroptosis of acute lymphoblastic leukemia cells by regulating miR-494-3p/NET1 axis. Circ_0000745/ miR-494-3p/NET1 axis may provide novel potential targets for the diagnosis and treatment of acute lymphoblastic leukemia (ALL). | |||
